Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak(Harvard University), A. John Iafrate(Massachusetts General Hospital), Ravi Salgia(City Of Hope National Medical Center), Woo Ho Kim(Seoul National University), Panos Fidias(Massachusetts General Hospital), Leena Gandhi(Celldex Therapeutics (United States)), Marileila Varella‐Garcia(University of Colorado Anschutz Medical Campus), Daniel A. Haber(Howard Hughes Medical Institute), Jeffrey A. Engelman(Cancer Research Center), Daniel B. Costa(Beth Israel Deaconess Medical Center), Geoffrey I. Shapiro(Brigham and Women's Hospital), Benjamin Solomon(Peter MacCallum Cancer Centre), Pasi A. Jänne(Harvard University), Keith D. Wilner(Pfizer (United States)), Mark J. Ratain(University of Chicago), Robert G. Maki(Memorial Sloan Kettering Cancer Center), Mari Mino–Kenudson(Massachusetts General Hospital), James G. Christensen, Lecia V. Sequist(Harvard University), Hannah Stubbs(Harvard University), Alice T. Shaw(Dana-Farber Cancer Institute), D. Ross Camidge(University of Colorado Denver), Jeffrey Settleman(Enzo Life Sciences (United States)), Sai‐Hong Ignatius Ou(University of California, Irvine Medical Center), Jeffrey W. Clark(Massachusetts General Hospital), Greg C. G. Wei(Pfizer (United States)), Yung‐Jue Bang(Seoul National University), Bruce J. Dezube(Xilio Therapeutics (United States)), Weiwei Tan(Memorial Sloan Kettering Cancer Center), S. Martin Shreeve(Janssen (United States)), Thomas J. Lynch(Nationwide Children's Hospital)
Cited by 4,516
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k